ValuEngine lowered shares of Ingevity (NYSE:NGVT) from a buy rating to a hold rating in a report published on Tuesday.

Several other brokerages have also recently weighed in on NGVT. Berenberg Bank cut shares of Ingevity from a buy rating to a hold rating and set a $110.00 price target on the stock. in a research report on Tuesday, October 2nd. Zacks Investment Research cut shares of Ingevity from a strong-buy rating to a hold rating in a research report on Tuesday, September 25th. KeyCorp raised their price target on shares of Ingevity from $95.00 to $110.00 and gave the company an overweight rating in a research report on Friday, July 27th. Loop Capital set a $98.00 price target on shares of Ingevity and gave the company a hold rating in a research report on Thursday, August 16th. Finally, Oppenheimer raised their price target on shares of Ingevity from $90.00 to $100.00 and gave the company an outperform rating in a research report on Thursday, July 26th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus price target of $101.44.

Shares of NYSE NGVT opened at $88.63 on Tuesday. Ingevity has a fifty-two week low of $66.57 and a fifty-two week high of $106.59. The stock has a market capitalization of $3.78 billion, a P/E ratio of 34.78, a price-to-earnings-growth ratio of 2.01 and a beta of 1.22. The company has a current ratio of 2.58, a quick ratio of 1.48 and a debt-to-equity ratio of 2.09.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, July 25th. The company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.13. Ingevity had a net margin of 14.72% and a return on equity of 46.65%. The business had revenue of $308.60 million for the quarter, compared to analysts’ expectations of $305.14 million. During the same quarter last year, the firm earned $0.78 EPS. The firm’s revenue for the quarter was up 18.6% compared to the same quarter last year. As a group, sell-side analysts expect that Ingevity will post 3.72 earnings per share for the current year.

Several institutional investors have recently bought and sold shares of NGVT. FMR LLC lifted its position in shares of Ingevity by 240.1% during the 2nd quarter. FMR LLC now owns 866,464 shares of the company’s stock worth $70,062,000 after buying an additional 611,676 shares in the last quarter. BlackRock Inc. lifted its position in shares of Ingevity by 7.8% during the 2nd quarter. BlackRock Inc. now owns 5,985,960 shares of the company’s stock worth $484,025,000 after buying an additional 431,313 shares in the last quarter. Summit Trail Advisors LLC lifted its position in shares of Ingevity by 8,223.0% during the 1st quarter. Summit Trail Advisors LLC now owns 367,711 shares of the company’s stock worth $368,000 after buying an additional 363,293 shares in the last quarter. Artisan Partners Limited Partnership bought a new position in shares of Ingevity during the 2nd quarter worth approximately $19,759,000. Finally, Segall Bryant & Hamill LLC lifted its position in shares of Ingevity by 194.1% during the 2nd quarter. Segall Bryant & Hamill LLC now owns 240,238 shares of the company’s stock worth $19,426,000 after buying an additional 158,549 shares in the last quarter. 92.04% of the stock is currently owned by hedge funds and other institutional investors.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems.

Featured Article: Yield Curve

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.